Suchergebnisse - (Standardsuche:"novel coronavirus" OR Covid OR "Sars-CoV" OR "CoV-2" OR ncov)

PubPharm (766)

761

Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection who have no comorbidities like diabetes mellitus: A structured summary of a study protocol for a randomized controlled trial

in: Trials | 2020

von Javed Akram | Shehnoor Azhar | Muhammad Shahzad | +2

762

Efficacy of local budesonide therapy in the management of persistent hyposmia in COVID-19 patients without signs of severity: A structured summary of a study protocol for a randomised controlled trial

in: Trials | 2020

von Mary Daval | Alain Corré | Clement Palpacuer | +12

763

PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial

in: Trials | 2020

von Oriana Nanni | Pierluigi Viale | Bernadette Vertogen | +18

764

Adding Colchicine to the Antiretroviral Medication - Lopinavir/Ritonavir (Kaletra) in Hospitalized Patients with Non-Severe Covid-19 Pneumonia: A Structured Summary of a Study Protocol for a Randomized Controlled Trial

in: Trials | 2020

von Nooshin Dalili | Alireza Kashefizadeh | Mohsen Nafar | +6

765

Hyperimmune anti-COVID-19 IVIG (C-IVIG) Therapy for Passive Immunization of Severe and Critically Ill COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial

in: Trials | 2020

von Shaukat Ali | Shobha Luxmi | Fatima Anjum | +12

766

A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial

in: Trials | 2020

von Mohammad Bosaeed | Ebrahim Mahmoud | Mohammad Hussein | +13

[1]
« Vorheriger
67
68
69
70
71
72
73
74
75
76
77